Growth Capital For Life Sciences & Healthcare

Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.

We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.

Our Strategy

Latest News & Announcements

Akoya Biosciences Announces Pricing of Initial Public Offering

April 16th, 2021|

MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its initial public offering of 6,580,000 shares of its common stock at a price of $20.00 per share, for gross proceeds of $131.6 milli [...]

Bio-Techne to Acquire Asuragen

March 3rd, 2021|

MINNEAPOLIS and AUSTIN, Texas, March 3, 2021  /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Asuragen, [...]

View all news